Used in cancer research to disrupt mitotic spindle formation by inhibiting the kinesin motor protein Eg5, leading to cell cycle arrest in dividing cells. Shows potential as an antimitotic agent for developing anticancer therapies, particularly in targeting tumor cells with high mitotic activity. Also employed in biochemical assays to study kinesin-driven microtubule dynamics and mitotic mechanisms.